🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double blind Phase I study to evaluate the safety, tolerability, ...
Status
Unknown
Location
PKUCare Luzhong Hospital
Start Date
2018-09-07
Trial ID
NCT03641794
This early phase trial proposes to study of stereotactic body radiation the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05469490
Treatments Being Tested
The primary purpose of this research study is to assess whether the partici...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-07
Trial ID
NCT01822691
Treatments Being Tested
This phase I trial studies the side effects of nivolumab, BMS-986205, and s...
Status
Active Not Recruiting
Location
Northwestern University
Start Date
2019-08-13
Trial ID
NCT04047706
The purpose of this study was to evaluate the efficacy and safety of pembro...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2018-01-09
Trial ID
NCT03322566
Treatments Being Tested
The purpose of this study is to demonstrate the safety and preliminary acti...
Status
Completed
Location
Local Institution - 0006
Start Date
2018-05-30
Trial ID
NCT03459222
Treatments Being Tested
This phase II trial studies how well nivolumab works, with or without BMS98...
Status
Active Not Recruiting
Location
Ohio State University
Start Date
2019-04-09
Trial ID
NCT03854032
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of...
Status
Completed
Location
Alaska Womens Cancer Care Akwcc
Start Date
2021-01-26
Trial ID
NCT04463771
Treatments Being Tested
The purpose of this study is to test any good and bad effects of the combin...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2018-01-23
Trial ID
NCT03414229
Treatments Being Tested
The purpose of this study is to evaluate the safety of the study drug LY338...
Status
Terminated
Location
IU Simon Cancer Center
Start Date
2017-11-17
Trial ID
NCT03343613